In a deal valued at $430 million, Holland & Knight partners Rodney Bell and Danielle Price advised Sunovion Pharmaceuticals Inc. on its acquisition of Elevation Pharmaceuticals and the company's lead drug, EP-101.
October 10, 2012 at 12:00 AM
1 minute read
Dealmakers: Rodney Bell and Danielle Price
The Deal: The Holland & Knight partners advised Sunovion Pharmaceuticals Inc. on its acquisition of Elevation Pharmaceuticals and the company’s lead drug, EP-101, an inhalation product for treating chronic obstructive pulmonary disease.
Presented by BigVoodoo
Join the industry's top owners, investors, developers, brokers & financiers at THE MULTIFAMILY EVENT OF THE YEAR!
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Lower Manhattan firm seeks a premises liability litigator (i.e., depositions, SJ motions, and/or trials) with at least 3-6 years of experien...
At NJM, a top-rated insurance company, we are seeking an Attorney on our Workers Compensation legal team with between 3 and 5 years of expe...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
